Nordic pharmaceutical market growth during February–October 2008 was approximately 4%, varying between -0.6% in Norway and 7.5% in Denmark. The higher than expected growth in Denmark results from substantial deliveries to hospitals and does not represent the development in private pharmacies.

In Estonia and Latvia, the double-digit market growth continued in spite of the economic situation. The Baltic markets are characterised by high inflation and an overall weak economic outlook. The market growth continued steady in Poland during third quarter.

Legislative measures to restrict the rise in pharmaceutical costs continued in Tamro’s entire market area.